ANTHRASIL®
ANTHRASIL is an Anthrax Immune Globulin Intravenous (Human) indicated for the treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs. The effectiveness of ANTHRASIL is based solely on efficacy studies conducted in animal models of inhalational anthrax.
Availability: Commercially Available
| Manufacturer |
| Emergent BioSolutions, Inc. |
| Product Name |
| ANTHRASIL® |
| Detection Category |
| Biological |
| Detection Method |
| Medical Countermeasure |
| Application |
| Personal Protective Equipment; |
| Equipment Type |
| PPE |
| Product Synopsis |
| ANTHRASIL is an Anthrax Immune Globulin Intravenous (Human) indicated for the treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs. The effectiveness of ANTHRASIL is based solely on efficacy studies conducted in animal models of inhalational anthrax. |
| Availability |
| Commercially Available |
| Technology Readiness Level (TRL) |
| 9 |
| Market Entry Date |
| 2015 |
| User Feedback Sources |
| Indifferent/No user feedback |
| Weight |
| <1 lb. |
| Power Requirements |
| None |
| Transportability |
| Pocket Size |
| Live Agent Tested |
| Yes; B. anthracis (anthrax) |
| Operating Time |
| Immediate post-exposure use |
| Standards Met |
| FDA |
| Training Required |
| <1 hour training |
| Training Available |
| Yes |
| Manuals Available |
| Yes |
